Online Media Kit
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
FEATURED STORY
November 30, 2020 | New York Times
Berry-Flavored H.I.V. Medication Is Ready for Babies
The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »
FEATURED STORY
July 30, 2020 | Aidsmap (UK)
The vaginal ring against HIV: regulatory approval for a new prevention choice for women
The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »
FEATURED STORY
July 24, 2020 | Times LIVE (South Africa)
Vaginal ring gives women more options for HIV prevention
Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »
Media Highlights
July 30, 2020 | Aidsmap (UK)
The vaginal ring against HIV: regulatory approval for a new prevention choice for women
The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »
July 29, 2020 | Radio VOP (Zimbabwe)
Dapivirine Ring-another HIV prevention tool for women
The prospects of women in Sub Saharan Africa accessing a long acting HIV prevention tool that gives them control over their sexual health, increased last Friday after an independent scientific agency... More »
July 29, 2020 | Medscape
EMA Backs Dapivirine Vaginal Ring for HIV Prevention Outside of EU
The CHMP of the EMA has adopted a positive opinion on the dapivirine vaginal ring for the reduction of risk for HIV infection women in low- and middle-income countries outside the European Union. More »
July 29, 2020 | Apotheke Adhoc (Germany)
Dapivirin: HIV-Prävention für Frauen
The vaginal ring releases the antiretroviral agent dapivirine over 30 days and thus offers a discreet and long-term HIV prevention method. More »
July 28, 2020 | The Pink Sheet
Dapivirine HIV Ring: A Gamechanger For African Women
The EU’s backing for the ring is being seen as a welcome addition to efforts to tackle the spread of HIV in lower resourced countries, particularly in sub-Saharan Africa. More »